TMCnet News
Dystonia Pipeline Insights, 2017: Pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type - Research and MarketsResearch and Markets has announced the addition of the "Dystonia - Pipeline Insights, 2017" drug pipelines to their offering. Dystonia - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Dystonia. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Dystonia. This report also assesses the Dystonia therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. Scope: ul>
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/65s2d5/dystonia
View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005507/en/ |